Related topics: Products & Markets
Italian biotechnology company IRB has extended its patent on the preparation and use of cell line cultures from the common lilac in the US.
The company says the active ingredient in the extract, verbascoside, is an effective antioxidant and anti-inflammatory agent.
In addition, it has an inhibitory effect on 5-alpha-reductase, an enzyme that plays a role in acne and hair loss, the company claimed.
According to IRB, the patent opens up opportunities for its US clients working in the cosmetics, nutrition and pharmaceutical areas.
Copyright - Unless otherwise stated all contents of this web site are © 2000/2010 - Decision News Media SAS - All Rights Reserved - For permission to reproduce any contents of this web site, please email our Syndication department: Administration & Finance - Full details for the use of materials on this site can be found in the Terms & Conditions
Food & Beverage: Food & Beverage Development - Europe | Food & Beverage Development - North America | Food Marketing and Retailing | Food Processing & Packaging | Food Safety & Quality Control | Food and Beverage in Asia Pacific | Industrial Baking & Snacks | Beverage Technology & Markets | Confectionery & Biscuit Processing | Dairy Processing & Markets | Prepared Food and Meat Processing | Retail news Nutrition: Supplements & Nutrition - Europe | Supplements & Nutrition - North America Pharmaceutical: Pharmaceutical Technology | Contract Research, Manufacturing & Clinical Trials Cosmetics: Cosmetics Formulation & Packaging - North America | Cosmetics Formulation & Packaging - Europe
About us | Site map | All sites | Recommend this Site | Advertise | Contact the Editor | Terms & Conditions | Privacy Policy
©; 2000/2010 - Decision News Media SAS - All right reserved.
